2026 Strategic Molecule Briefing: 2-Fluoro-3-Nitrobenzoic Acid (CAS 317-46-4)

The "Trifunctional" Architecture: A Synthetic Swiss Army Knife

In the high-stakes synthesis landscape of 2026, 2-Fluoro-3-Nitrobenzoic Acid (CAS 317-46-4) is recognized as a High-Density Scaffold. Unlike linear intermediates, this molecule packs three powerful functional groups onto a single benzene ring, each acting as a tactical "hook" for complex molecular assembly.

The Chemical Crossroad:

The Carboxylic Acid (-COOH):

Your primary anchor. In 2026, its role has shifted toward complex peptide-coupling and high-yield amidation for targeted drug delivery.

The Nitro Group (-NO₂):

A latent powerhouse. It acts as the gateway to the amino group (-NH2), allowing for the construction of nitrogen-heavy heterocycles or the addition of secondary aromatic rings.

The Ortho-Fluorine (-F):

The "Activator." Its position adjacent to the acid group creates a strong inductive effect, making the ring exceptionally susceptible to Nucleophilic Aromatic Substitution (SNAr). This allows chemists to swap the fluorine for various nucleophiles with surgical precision.

Product Insights: The Chemical Intelligence

What is this Molecule?

Technically, it is an aromatic carboxylic acid (C7H4FNO4). Strategically, it is a regioselective masterpiece. In 2026, the demand for "pre-substituted" rings is at an all-time high because they eliminate the unpredictable nature of late-stage aromatic substitution.

Strategic Applications

The "Broflanilide" Connection:

It is the core precursor for meta-diamide insecticides. As pests evolve resistance to earlier generations, the trifluoromethyl and nitro-substituted scaffolds provided by this acid are essential for maintaining global crop yields.

Next-Gen Quinolones:

Critical for the synthesis of advanced antibiotics. The 2-fluoro position is non-negotiable for ensuring the molecule correctly docks with bacterial DNA-gyrase.

Cysteine Protease Inhibitors:

Used in cutting-edge pharmaceutical research to develop treatments for chronic inflammatory diseases and viral replication.

The EASTFINE Advantage: Solving the "Isomer Headache"

The industrial challenge with CAS 317-46-4 has always been Nitration Leakage. During synthesis, the nitro group naturally tends to land on the 5-position rather than the 3-position.

The Industry Problem:

Many suppliers provide a mixture of isomers that reduces downstream yield by as much as 15–20%.

The EASTFINE Solution:

We utilize a 2026-standard low-temperature, phase-controlled nitration technique. By strictly managing the kinetics, we lock the nitro group into the 3-position, delivering a consistent ＞ 99% Isomeric Purity.

Technical Properties & "Process DNA"

Physical State:

High-purity crystalline powder.

Melting Point:

138°C – 140°C. A sharp, narrow melting range is the "fingerprint" of our purification process.

Acidity:

A remarkably high acidity for a benzoic acid (pKa ≈ 2.32), which facilitates faster reaction times in catalytic esterification.

The Synthetic "Surgical" Route

EASTFINE has moved away from traditional, waste-heavy nitration. Our 2026 route involves the selective oxidation of 2-fluoro-3-nitrotoluene. By employing an electrolytic oxidation process, we have eliminated heavy-metal catalysts from the equation. This makes our product "Green Chemistry" compliant—a major requirement for 2026 ESG audits.

Handling & "Shelf-Life Intelligence"

This molecule is Hygroscopic. Without proper climate-controlled packaging, it will absorb moisture and begin to decarboxylate. EASTFINE ships exclusively in dual-layer, moisture-barrier PE liners inside fiber drums, guaranteed for 24-month stability.

2026 Global Manufacturer Landscape: The Industry Leaders

In 2026, the global supply chain for this intermediate is defined by a few key players, each serving distinct segments of the pharmaceutical and agrochemical sectors.

1. EASTFINE (The Strategic Partner)

EASTFINE bridges the gap between research-scale precision and mass-market industrial requirements. As a specialized pharmaceutical and agrochem intermediate company, we provide more than just the molecule; we deliver a comprehensive 2026 Impurity Profile Study with every batch. We are recognized for our 30-year legacy of Honesty, Professionalism, and Collaboration, ensuring that our regioselective purity (>99.5%) remains the industry benchmark.

2. Thermo Scientific Chemicals

Specialty: Providing ultra-pure (99.9%+) reagents for the earliest stages of laboratory R&D.

Limit: While they set the standard for lab-scale quality, their pricing model and logistics are rarely optimized for the multi-ton industrial requirements of 2026 campaigns.

3. Apollo Scientific

Specialty: They maintain massive stock levels in the UK and EU, making them the "Emergency Supplier" for the European market.

Limit: They are primarily a distributor/stockist, meaning they lack the direct control over the synthetic route that a primary manufacturer like EASTFINE possesses.

4. Simson Pharma Limited

Specialty: Excellent at taking complex molecules from grams to kilograms. They are a preferred partner for the thriving Indian generic pharmaceutical sector.

Limit: Their focus is often split across thousands of custom synthesis projects, unlike EASTFINE's dedicated production lines for core intermediates.

5. Fluorochem

Specialty: Renowned for chemical diversity; if you need an obscure derivative of CAS 317-46-4, Fluorochem likely has it in their catalog.

Limit: Primarily focused on the "catalog business" for researchers rather than the industrial-scale supply chain.

Why This Molecule is Industrially Critical in 2026

In 2026, Metabolic Tuning is the holy grail of drug design. The fluorine atom in the 2-position of this acid acts as a "metabolic shield." It prevents the human body (or target pests) from breaking the molecule down too quickly. This results in:

Lower Dosages:

Better for patient health and environmental impact.

Higher Persistence:

Crucial for long-lasting crop protection in agriculture.

Patent Shielding:

Strategically introducing a fluorine atom into a known scaffold is a common 2026 method for extending the commercial life of a pharmaceutical patent.

The Bottom Line: Why EASTFINE?

We don't just sell CAS 317-46-4; we provide Chemical Certainty. In a year where supply chain stability is paramount, EASTFINE offers a stable, high-purity, and isomer-perfect supply. We are the partner that understands that your final API or agrochemical active is only as good as the intermediate it is built upon.